Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
30/4 10:51
The market for obesity drugs presents one of the most lucrative targets for biopharmaceutical companies. Eli Lilly and Novo Nordisk are already raking in billions of dollars in sales with their weight-loss drugs. Other drugmakers are eyeing the market as well....